| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.007 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.007 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.009 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |